{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:23:04Z","timestamp":1762078984120,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FU356\/12-1"],"award-info":[{"award-number":["FU356\/12-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.amjcard.2023.06.006","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:30:38Z","timestamp":1687480238000},"page":"116-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Septal Microsphere Embolization in Hypertrophic Obstructive Cardiomyopathy"],"prefix":"10.1016","volume":"201","author":[{"given":"Emyal","family":"Alyaydin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf Alexander","family":"J\u00e1nosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Luedike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tienush","family":"Rassaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2801-7942","authenticated-orcid":false,"given":"Maria","family":"Papathanasiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.06.006_bib0001","first-page":"e558","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0002","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2018.08.062","article-title":"Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a propensity score-matched cohort","volume":"157","author":"Nguyen","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0004","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12471-013-0393-z","article-title":"Microsphere embolisation as an alternative for alcohol in percutaneous transluminal septal myocardial ablation","volume":"21","author":"Vriesendorp","year":"2013","journal-title":"Neth Heart J"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0005","article-title":"Advances in biomaterials and technologies for vascular embolization","volume":"31","author":"Hu","year":"2019","journal-title":"Adv Mater"},{"issue":"suppl 2","key":"10.1016\/j.amjcard.2023.06.006_bib0006","article-title":"Targeted septal branch microcirculatory embolization with tris-acryl gelatin microspheres in hypertrophic obstructive cardiomyopathy","volume":"41","author":"Okutucu","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0007","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/eurheartj\/eht227","article-title":"Transcoronary septal ablation in hypertrophic obstructive cardiomyopathy by embolizing microspheres","volume":"34","author":"Dickmann","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0008","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.jacc.2016.05.002","article-title":"The father of septal myectomy for obstructive HCM, who also had HCM: the unbelievable story","volume":"67","author":"Maron","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0009","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","article-title":"Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy","volume":"346","author":"Sigwart","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0010","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/eurheartj\/ehv693","article-title":"Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry","volume":"37","author":"Veselka","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007161","article-title":"Impact of demographic features, lifestyle, and comorbidities on the clinical expression of hypertrophic cardiomyopathy","volume":"6","author":"Finocchiaro","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007230","article-title":"Temporal trend of age at diagnosis in hypertrophic cardiomyopathy: an analysis of the international sarcomeric human cardiomyopathy registry","volume":"13","author":"Canepa","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0013","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jacc.2017.02.080","article-title":"Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a word of endorsement","volume":"70","author":"Liebregts","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0014","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamacardio.2016.0252","article-title":"Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US nationwide inpatient database, 2003-2011","volume":"1","author":"Kim","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0015","first-page":"270","article-title":"The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy","volume":"83","author":"Samardhi","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0016","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2016.06.127","article-title":"Short and long-term outcomes of alcohol septal ablation with the trans-radial versus the trans-femoral approach: a single center-experience","volume":"220","author":"Sawaya","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0017","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/clc.23697","article-title":"Outcome of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: A comparison with medical therapy","volume":"44","author":"Li","year":"2021","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0018","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2009.08.680","article-title":"Correlation between serum cardiac markers and myocardial infarct size quantified by myocardial perfusion imaging in patients with hypertrophic cardiomyopathy after alcohol septal ablation","volume":"105","author":"Hage","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0019","doi-asserted-by":"crossref","first-page":"E769","DOI":"10.25270\/jic\/20.00658","article-title":"Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a 16-year experience","volume":"33","author":"Fernandes","year":"2021","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.006_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024656","article-title":"Cardiac myosin inhibitors as a novel treatment option for obstructive hypertrophic cardiomyopathy: addressing the core of the matter","volume":"11","author":"Masri","year":"2022","journal-title":"J Am Heart Assoc"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923003752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923003752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:07:50Z","timestamp":1762078070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923003752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":20,"alternative-id":["S0002914923003752"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.006","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Septal Microsphere Embolization in Hypertrophic Obstructive Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}